|
General Information
|
|
|
Product
|
PDE11A4 Peptide
|
|
Description
|
Antigenic Blocking Peptide Phosphodiesterase 11A4 Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic Peptide
|
|
Accession #
|
GenBank: BAB62712.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol |
|
Protein
|
|
Uniprot #
|
Q9HCR9
|
|
Overview
|
Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides cAMP and cGMP. Catalyzes the hydrolysis of both cAMP and cGMP to 5'-AMP and 5'-GMP, respectively.
|
|
Molecular Function
|
Hydrolase, 3', 5'-cyclic-GMP phosphodiesterase activity, cGMP binding
|
|
Subcellular Location
|
Cytoplasm
|
|
Expression
|
Isoform 1 is present in prostate, pituitary, heart and liver. It is however not present in testis nor in penis, suggesting that weak inhibition by Tadalafil is not relevant (at protein level). Isoform 2 may be expressed in testis. Isoform 4 is expressed i
|
|
Alternative Nomenclature
|
cGMP phosphodiesterase 11A antibody
Pde11a antibody
Pde11A2 antibody
Pde11A3 antibody
PDE11A4 antibody
PPNAD2 antibody
|
| |
|
PDE11A4 Antibody
PDE11A4 Antibody FITC
PDE11A4 Antibody BIOTIN
PDE11A4 Positive Control
